Indeed, the longer Anthem continues to design and administer the obesity exclusion, the more it puts the health and lives of its enrollees diagnosed with obesity at risk for the many symptoms and co-occurring conditions associated with obesity. Holland, the lawsuit says, is enrolled in an Anthem plan through her employer, Falmouth schools, and was subjected to disability discrimination by Anthem because she is diagnosed with obesity, a (disabling) health condition, and she requires treatment with medically necessary prescription medications for that health condition. Obesity exclusions in insurance policies violate the Affordable Care Act, which protects people with disabilities, including those with obesity, according to the lawsuit
Geraldi M
Weight-management trials of semaglutide 2.4 mg report mean reductions of roughly 15%, and higher with the 7.2 mg dosage
If side effects from semaglutide are persistent and difficult to manage, discussing a switch to tirzepatide with a provider might be an option, as the body might react differently to the other active ingredient
No, but most patients who stop GLP-1 regain 5070% of lost weight within 12 months
Nonetheless, their adverse effects and safety profiles remain critical concerns in clinical practice
